Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)
- J Med Chem. 1999 Jan 28;42(2):210-2. doi: 10.1021/jm9806648.
Affiliations
- 1. Departments of Medicinal Chemistry, Endocrine Research, and New Leads Discovery, Ligand Pharmaceuticals, Inc., 10275 Science Center Drive, San Diego, California 92121, USA. [email protected]
PMID: 9925725
DOI: 10.1021/jm9806648